We are live on ! Find out more
AVNS icon

Avanos Medical

281 hedge funds and large institutions have $2.07B invested in Avanos Medical in 2020 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 50 increasing their positions, 95 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more capital invested

Capital invested by funds: $1.53B → $2.07B (+$541M)

29% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 35

3% more funds holding

Funds holding: 272281 (+9)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.62% less ownership

Funds ownership: 96.04%94.41% (-1.6%)

47% less repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 95

Holders
281
Holders Change
+9
Holders Change %
+3.31%
% of All Funds
4.97%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
45
Increased
50
Reduced
95
Closed
35
Calls
$1.11M
Puts
Net Calls
+$1.11M
Net Calls Change
+$1.17M
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$2.72M
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$2.71M -$308K -7,400 -11%
Russell Investments Group
53
Russell Investments Group
United Kingdom
$2.65M +$807K +19,386 +51%
Massachusetts Financial Services
54
Massachusetts Financial Services
Massachusetts
$2.62M -$24.1K -579 -1%
State of New Jersey Common Pension Fund D
55
State of New Jersey Common Pension Fund D
New Jersey
$2.61M -$490K -11,765 -17%
TD Asset Management
56
TD Asset Management
Ontario, Canada
$2.34M +$295K +7,086 +16%
Bank of America
57
Bank of America
North Carolina
$2.19M +$172K +4,121 +9%
MIM
58
MetLife Investment Management
New Jersey
$2.16M -$50.4K -1,211 -3%
UBS AM
59
UBS AM
Illinois
$2.13M -$320K -7,694 -14%
MOACM
60
Mutual of America Capital Management
New York
$2.04M -$3.54K -85 -0.2%
Ensign Peak Advisors
61
Ensign Peak Advisors
Utah
$1.9M
MAG
62
Millrace Asset Group
Pennsylvania
$1.89M -$344K -8,274 -17%
Deutsche Bank
63
Deutsche Bank
Germany
$1.87M -$3.24M -77,863 -66%
AG
64
Aperio Group
California
$1.84M +$400K +9,620 +32%
TPSF
65
Texas Permanent School Fund
Texas
$1.76M -$261K -6,269 -14%
CSS
66
Cubist Systematic Strategies
Connecticut
$1.75M -$129K -3,091 -8%
Man Group
67
Man Group
United Kingdom
$1.73M -$1.68M -40,389 -52%
ICOM
68
Investment Counselors of Maryland
Maryland
$1.64M +$72K +1,730 +5%
MC
69
Maverick Capital
Texas
$1.62M +$1.47M +35,372 New
GC
70
Guggenheim Capital
Illinois
$1.4M +$1.27M +30,518 New
Comerica Bank
71
Comerica Bank
Texas
$1.35M -$26.6K -638 -2%
KeyBank National Association
72
KeyBank National Association
Ohio
$1.25M -$44.1K -1,060 -4%
NSAM
73
North Star Asset Management
Wisconsin
$1.22M +$83 +2 +0%
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$1.2M -$2.1M -50,488 -66%
MSA
75
Mason Street Advisors
Wisconsin
$1.17M -$2.25K -54 -0.2%

AVNS Hedge Fund Activity: Q4 2020 in Review

281 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2020, worth a combined $2.07B — up 35% from $1.53B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new AVNS positions and 35 closed out — a net gain of 10 holders — while 50 added to existing stakes and 95 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $13.3M. The largest seller was Norges Bank, cutting an estimated $8.19M.

  • 281 institutional investors held Avanos Medical (AVNS) as of Q4 2020, up from 272 in Q3 2020.
  • Funds reported $2.07B of Avanos Medical stock for Q4 2020, up 35% quarter-over-quarter.
  • 45 funds opened new Avanos Medical positions in Q4 2020 and 35 closed out, a net change of +10 holders.
  • The largest Avanos Medical buyer in Q4 2020 was Wellington Management Group, an estimated $13.3M added.
  • The largest Avanos Medical seller in Q4 2020 was Norges Bank, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2020.